36C24921Q0544.docx

Sources Sought Notice Sources Sought Notice

GENERAL INFORMATION

SET-ASIDE

Network Contracting Office 9 (90C)

NCO 9

1639 Medical Center Parkway, Suite 400 Murfreesboro TN 37129

POINT OF CONTACT*

Contracting Officer LaShanda Harrington LaShanda.Harrington@va.gov

PLACE OF PERFORMANCE

Troy Bowling Campus

Room A139

1101 Veterans Drive

Lexington KY

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

The Department of Veterans Affairs Medical Center, Network Contracting Office (NCO) 9, on behalf of Lexington VAMC, 1101 Veterans Drive, Lexington, Ky 40502, is issuing this source sought synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a firm-fixed priced contract for BioPlex 2200 System Rental, Reagents and Consumables. The result of this market research will contribute to determining the method of procurement. The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 334516, size standard 1,000 Employees.

This is NOT a solicitation announcement at this time. This is a sources sought/RFI only. The purpose of this sources sought/RFI is to gain knowledge of potential qualified sources and their size classification relative to NAICS 334516 (size standard of 1,000 Employees). Responses to this source sought will be used by the Government to make appropriate acquisition decisions. Responses to this source sought synopsis are not considered adequate responses for a solicitation announcement. This request for capability information does not constitute a request for proposals or quotes; submission of any information in response to this market survey is purely voluntary; the government assumes no financial responsibility for any costs incurred. After review of the responses to this source sought, a solicitation announcement may be published.

The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 9, is seeking sources that can provide BioPlex 2200 System Rental, Reagents and that at a minimum meets the following salient characteristics with a brand name only product that have been validated, tested and approved for the Lexington VAMC and the below Statement of Work:

Period of Performance The period of performance will start shortly after award for a base year and four (4) option years.

Brand name Info:

Equipment Schedule and Test volume estimates:

BIO-RAD BIOPLEX 2200 COST PER REPORTABLES

BIO-RAD BIOPLEX 2200 REAGENTS & CONSUMABLES

Description/Specifications/Statement of Work:

1. The Special Reference Laboratory (SRL) located at the Lexington VA Health Care System provides laboratory testing for the serologic and molecular diagnosis of infectious disease and autoimmune disorders to any VA facility wishing to utilize its services. The tests offered are those that are too complex (e.g. Complement Fixation testing, Immunofluorescence Assay) or are not cost effective (e.g. HCV PCR and Genotyping, ENA, and ANA testing) at the local level.

2. The Special Reference Laboratory (SRL) is seeking a fully automated, walk away, fully integrated, random access, continuous feed Multiplex platform capable of high throughput. To provide higher throughput and increased sensitivity for low analytic concentrations, the VAMC SRL requires Multiplex technology. The VAMC SRL is seeking a Cost Per Reportable contract with a base plus four option years for instrumentation, reagents, consumables, and support for Autoimmune and Infectious Disease Multiplex testing.

3. The instrumentation must be capable of running our current ENA (Extractable Nuclear Antigen) menu (SS-A, SS-B, Sm, Sm/RNP, Scl-70, and Jo-1) as well as ANA (Anti-Nuclear Antibody) screens and Anti-CCP (Cyclic Citrullinated Peptide Antibody) and additional Autoimmune and Infectious Disease assays to add to our test menu (including Syphilis RPR and a HIV differential screen). All assays must be capable of running at one time for improved patient result turnaround times.

4. The test analyzer shall have the capability of performing or reporting the clinical parameters as defined in the statement of work. The instrument(s) shall be able to simultaneously perform the testing as described below and meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). To meet the testing requirements and perform tests in a timely manner, the instrument must be a fully automated, random access, continuous feed multiplex testing platform.

If you are interested and are capable of providing the supplies/services, please provide the requested information as well as the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions:

1. Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran Owned Small Business (SDVOSB), Veteran Owned Small Business (VOSB), HUBZone, Woman Owned Small Business (WOSB), Large Business, etc.)

2. Is your company considered small under the NAICS code identified under this RFI?

3. Are you the manufacturer or distributor of the items being referenced above (or equivalent product/solution)? What is the manufacturing country of origin of these items?

4. If you’re a small business and you are an authorized distributor/reseller for the items identified above (or equivalent product/solution), do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified? Provide written verification of authorized distributor/reseller.

5. If you are an FSS GSA/NAC or NASA SEWP contract holder or other federal contract holder, are the referenced items/solutions available on your schedule/contract? Provide contract number.

6. Please state your company’s DUNS number.

7. Please submit your capabilities in regard to the salient characteristics being provided and any information pertaining to “equal to items” to establish capabilities for planning purposes?

BASED ON THE RESPONSES TO THIS SOURCE SOUGHT NOTICE/MARKET RESEARCH, THIS REQUIREMENT MAY BE SET-ASIDE FULL AND OPEN COMPETITION. THE SUBMISSION OF PRICING, CAPABILITIES FOR PLANNING PURPOSES, AND OTHER MARKET INFORMATION IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI IN ACCORDANCE WITH (IAW) FAR 15.201(e). Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions. Submission Instructions: Interested parties who consider themselves qualified to provide these supplies/services are invited to submit a response to this Sources Sought Notice by 8:00 am CT, Thursday, August 26, 2021. All responses under this Sources Sought Notice must be emailed to LaShanda.Harrington@va.gov, Subject Line Title: BioPlex 2200 System Rental, Reagents and Consumables.

SAM: Interested parties shall be register in the System for Award Management (SAM) as prescribed in FAR Clause 52.232-33. The SAM can be obtained by accessing the internet at www.SAM.gov or by calling 1-866-606-8220.

DISCLAIMER

This RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.

Sources Sought Notice